Memorial Sloan Kettering Cancer Center is the Best Oncology Hospital in the World according to Newsweek

Memorial Sloan Kettering Cancer Center (MSK) is ranked the number one hospital in the world for oncology according to Newsweek's World's Best Specialized Hospitals 2026 list.

"Earning the distinction as the world's top hospital for oncology is a profound honor that reflects the exceptional work of our entire team," said Selwyn M. Vickers, MD, FACS, President and CEO of MSK. "Their unwavering dedication to compassionate care, paired with our pursuit of pioneering research and commitment to training future scientists advance our mission: ending cancer for life."

The World's Best Specialized Hospitals 2026 ranking recognizes the top hospitals across key specialties, including Cardiac Surgery, Cardiology, Endocrinology, Gastroenterology, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedics, Pediatrics, Pulmonology, and Urology. The analysis is based on three data sources: hospital recommendations from peers, accreditations, and the implementation of patient-reported outcome measures (PROMs).

"Our patients are the inspiration behind our mission," said Dr. Vickers. "Every decision we make is driven by a bold commitment to redefine what's possible for each patient. We relentlessly pursue exceptional outcomes and a future where every patient experience sets a new standard."

Memorial Sloan Kettering's recognition as the world's top hospital for oncology reflects its exceptional contributions to patient care, research, and education. Since 2015, MSK has earned accolades from Press Ganey, a leading research firm and strategic partner organization, for delivering outstanding patient experience. MSK has also played a pivotal role in clinical trials that have led to the FDA approval of 11 new cancer drugs. Its nursing staff has received the Magnet Recognition Program® designation three times- the highest national honor for nursing excellence. MSK continues to expand access to cancer screening, advance genomic-based diagnosis and treatment, and pioneer innovations that are shaping the future of oncology.